Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown

被引：0
|
作者：
Xiaodong Qin
Yuping Du
Xing Chen
Wuyan Li
Jinghong Zhang
Jinbo Yang
机构：
[1] Lanzhou University,School of Life Science
[2] Muskingum University,Department of Engineering Science
[3] Huaqiao University,School of Biomedical Science and Institutes of Molecule Medicine
[4] Lerner Research Institute,Department of Cancer Biology
[5] The Cleveland Clinic Foundation,undefined
来源：
Cell & Bioscience | / 4卷
关键词：
H1299 Cell; Pyruvate Kinase; PI3K Inhibitor; Knockdown Efficiency; Metabolic Reprogram;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PKM2 knockdown influences SREBP activation and lipid synthesis in bovine mammary-gland epithelial MAC-T cells
    Su, Bing-Qian
    Han, Ying-Qian
    Fan, Shuang-Shuang
    Ming, Sheng-Li
    Wan, Bo
    Lu, Wei-Fei
    Chu, Bei-Bei
    Yang, Guo-Yu
    Wang, Jiang
    BIOTECHNOLOGY LETTERS, 2018, 40 (04) : 641 - 648
  • [32] Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
    Lu, Wei-Qun
    Hu, Ying-Ying
    Lin, Xiao-Ping
    Fan, Wei
    ONCOTARGET, 2017, 8 (27) : 44171 - 44185
  • [33] Plumbagin Protects Mice from Lethal Sepsis by Modulating Immunometabolism Upstream of PKM2
    Zhaoxia Zhang
    Wenjun Deng
    Rui Kang
    Min Xie
    Timothy Billiar
    Haichao Wang
    Lizhi Cao
    Daolin Tang
    Molecular Medicine, 2016, 22 : 162 - 172
  • [34] Plumbagin Protects Mice from Lethal Sepsis by Modulating Immunometabolism Upstream of PKM2
    Zhang, Zhaoxia
    Deng, Wenjun
    Kang, Rui
    Xie, Min
    Billiar, Timothy
    Wang, Haichao
    Cao, Lizhi
    Tang, Daolin
    MOLECULAR MEDICINE, 2016, 22 : 162 - 172
  • [35] Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
    Sun, Wei
    Ge, Yang
    Cui, Junpeng
    Yu, Yifan
    Liu, Baolin
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 : 87 - 97
  • [36] RETRACTED: Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin (Retracted Article)
    Wang, Feng
    Yang, Yong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 454 (03) : 465 - 470
  • [37] MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells
    Yuxin Yang
    Qiuyu Meng
    Chen Wang
    Xiaonan Li
    Yanan Lu
    Xiaoru Xin
    Qidi Zheng
    Dongdong Lu
    Journal of Molecular Medicine, 2018, 96 : 1119 - 1130
  • [38] MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells
    Yang, Yuxin
    Meng, Qiuyu
    Wang, Chen
    Li, Xiaonan
    Lu, Yanan
    Xin, Xiaoru
    Zheng, Qidi
    Lu, Dongdong
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (10): : 1119 - 1130
  • [39] Changing the metabolism of cancer cells with PKM2 activators - a path to a cancer metabolism drug
    Behar, Vered
    Bohana-Kashtan, Osnat
    Shitrit, Alina
    Ben-Zeev, Efrat
    Konson, Alexander
    Ozeri, Rachel
    Kehat, Tzofit
    Mirilashvili, Sima
    Schutz, Nili C.
    Yacovan, Avihai
    Becker, Oren M.
    CANCER RESEARCH, 2012, 72
  • [40] The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose
    Xiang Li
    Shichang Deng
    Mingliang Liu
    Yan Jin
    Shuai Zhu
    Shijiang Deng
    Jingyuan Chen
    Chi He
    Qi Qin
    Chunyou Wang
    Gang Zhao
    Cell Death & Disease, 9
12345